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Primary stenting for aortic lesions: From single
stenoses to total aortoiliac occlusions
Chris Klonaris, MD, Athanasios Katsargyris, MD, Nikolaos Tsekouras, MD, Andreas Alexandrou, MD,
Athanasios Giannopoulos, MD, and Elias Bastounis, MD, Athens, Greece
Purpose: This study evaluated the feasibility, safety, and efficacy of primary stenting in atherosclerotic stenoses and
occlusions of the infrarenal aorta.
Methods: Between January 2003 and December 2006, 12 patients (6 men) with a mean age of 66.3  4.1 years who had
infrarenal aortic occlusive disease were treated with primary stenting (aortic stenosis, 8; chronic total aortobiiliac
occlusion, 4). Reasons for referral were severe claudication in six patients (50%), ischemic rest pain in four (33.3%), and
minor tissue loss in two (16.7%). Three patients (25%) had chronic renal failure and were on dialysis. Follow-up was
performed in all 12 patients.
Results: Technical success was 91.7% because one patient had a residual stenosis >30% after stent placement and balloon
postdilation owing to severe calcification of the aorta. However, clinical and immediate hemodynamic success was
achieved in all 12 patients (100%). The preprocedural mean resting ankle-brachial index (ABI) values of 0.56  0.13 at
the right side and 0.59  0.15 at the left were increased to 0.97  0.04 and 0.95  0.06, respectively, after treatment
(P < .01). At the end of the mean follow-up of 18.3 months (range, 6-37 months), the primary clinical and hemodynamic
patency was 91.7%  7.98%, and the mean resting ABI values were 0.96  0.04 for the right and 0.92  0.1 for the left
side (P < .01 compared with preinterventional values). None of the patients in the study underwent reintervention. An
access-related groin hematoma developed in one patient, but no other major or minor complications occurred. One
patient died 8 months after the procedure of chronic renal failure complications.
Conclusion: Primary stenting is feasible, safe, and effective for the whole spectrum of aortic occlusive disease. Especially
for patients with infrarenal aortic stenoses, it is recommended as the first-line treatment and should be considered as a
viable alternative to surgery for total aortoiliac occlusions. ( J Vasc Surg 2008;47:310-7.)Two different patterns of atherosclerotic disease affect
the infra-renal aorta: (1) localized lesions of the aortic
bifurcation involving the lower part of the abdominal aorta
and the common iliac arteries, whether symmetric or not,
and (2) isolated lesions of the infrarenal aorta without
involvement of the aortic bifurcation. The latter pattern of
aortic occlusive disease is relatively rarely observed. It oc-
curs more frequently in women aged 30 to 50 years who are
heavy smokers.1
Surgery, either with bypass graft or aortic endarterec-
tomy, has been the traditional standard of care for infrare-
nal aortic occlusive disease, with good long-term patency
rates of 70% to 75% at 10 years but a 5% to 10% early
complication rate.2-4 Percutaneous transluminal angio-
plasty (PTA) has been proposed as an alternative to surgery,
and several series have demonstrated its safety and efficacy
in localized stenoses of the distal infrarenal aorta5-11 as well
as in lesions involving the aortic bifurcation.5-7,10
Stenting offers theoretic advantages over PTA, and its
use has been established in several vascular beds, with
excellent patency rates.12 In the infrarenal aorta, however,
only a small number of studies to date have evaluated the
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310results of primary stenting for localized stenoses,13-16
whereas total aortic occlusions have been conventionally
considered as a relative contraindication for endovascular
therapy. In this series, we report our experience with pri-
mary stenting for aortic occlusive disease, ranging from
single infrarenal aortic stenoses to extended chronic total
aortobiiliac occlusions.
METHODS
Patients. The medical records of all patients with aor-
tic occlusive disease ranging from isolated localized aortic
stenosis to total occlusion of the infrarenal aorta extending
or not to the iliac arteries that were treated using percuta-
neous endovascular techniques (PTA) techniques during
the period January 2003 to December 2006 were retro-
spectively analyzed for this study. Patients with aortic bi-
furcation lesions that actually represented iliac artery dis-
ease were not included in this analysis. Twelve patients met
the inclusion criteria. All patients provided informed con-
sent.
Atherosclerosis risk factors as well as preprocedural and
postprocedural clinical symptoms were registered in all
patients. Ankle-brachial indexes (ABIs) at rest were also
calculated. Patients with claudication had been offered
conservative treatment, including exercise programs along
with cardiovascular risk factor modification, for6months
before intervention; however, no significant clinical im-
provement was noticed in any of them.
Before admission in our department, 10 of the 12
patients were evaluated with digital subtraction angiogra-
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patients (50%) had isolated aortic stenosis without bifurca-
tion involvement (4 at the mid and 2 at the lower portion of
the infrarenal aorta). Five of these lesions were 3cm in
length (TransAtlantic Inter-Society Consensus [TASC] B),
and one was 3 cm. Four patients (33.3%) had chronic
total aortobiiliac occlusion (TASC D). One patient (8.3%)
had focal aortic stenosis and chronic occlusion of the right
common (CIA) and external iliac artery (EIA) extending to
the origin of the common femoral artery (CFA; TASC D).
Finally, the remaining patient (8.3%) had two separate
localized stenoses in the infrarenal aorta along with right
CIA stenosis and chronic left CIA and EIA occlusion
extending to the proximal CFA (TASC D). All stenoses
were of atherosclerotic origin and 60% as determined by
angiograms. All 12 patients had patent femoropopliteal
segments and good distal runoff scores 2.
Procedure. Stenting procedures were performed in
the endovascular suite of our department under local anes-
thesia supplemented with intravenous sedation and analge-
sia when indicated. The patients were monitored with pulse
oximetry, electrocardiography, and blood pressure. Preop-
eratively, all patients were receiving long-term antiplatelet
therapy.
Three different approaches were used with regard to
the localization and extent of the lesions.
1. For stenoses without bifurcation involvement lo-
cated at the mid segment of the infrarenal aorta, a unilateral
retrograde femoral approach was used. A long introducer
sheath with appropriate diameter (10F-12F) matching the
size of the intended stent was placed at the ipsilateral
common femoral artery, and a bolus of heparin (5000 IU)
was given intravenously. An initial angiography was then
performed through the introducer sheath.
The stenosis was crossed with a 0.035-in steerable
guidewire alone or combined with a selective catheter,
followed by direct aortic stenting. Self-expanding stents
were appropriately placed to well cover the entire lesion.
Balloon widening of the stents was carefully performed
with a single aortic dilation balloon (14-16 mm in diame-
ter) that was inflated 3 atm and was discontinued imme-
diately at any patient reaction indicating pain. When bal-
loon expandable stents were placed, they were advanced
protected in the long sheaths that were withdrawn after
appropriate stent positioning.
2. For distal isolated aortic stenoses located close to but
not involving the aortic bifurcation, the kissing technique
was used. Two 6F sheaths were introduced in both CFAs,
and the stenosis was bilaterally crossed with two steerable
guidewires. Iliac kissing stents were deployed appropri-
ately, well covering the aortic lesion. Stent widening was
performed with kissing balloons (8-9 mm in diameter).
3. In patients with chronic aortobiiliac occlusion, bilat-
eral, short 6F sheaths were introduced percutaneously
through the common femoral arteries. The occlusions were
crossed bilaterally using the coaxial technique with
0.035-in straight, stiff-type hydrophilic Terumo guidewires
combined with straight 4F hydrophilic catheters (TerumoCorp, Tokyo, Japan). Angled guidewires and catheters
were not used to avoid subintimal passage. Conservative
kissing predilation was then performed with small diameter
balloons of 6 to 8 mm to facilitate stent advancement; the
degree of dilation was much less than the estimated normal
vessel lumen to minimize the bulk of debris and the possi-
bility of distal embolization and avoid aortic rupture.
If initial aortic and iliac arteries recanalization was suc-
cessful, the 6F sheaths were exchanged for long sheaths of
appropriate size for stent advancement. Self-expanding aor-
tic stents were then positioned and deployed appropriately
in the infrarenal aorta, followed by simultaneous bilateral
deployment of the iliac “stent-limbs.” The latter were
placed in continuity with the aortic stents to trap the
possible generated atherothrombotic debris and to prevent
the development of a new lesion within the nonstented
segment of the aortic bifurcation.
At the end of the procedure, a completion angiogram
was performed for demonstration of the final result and
screening of asymptomatic distal embolization. Hemostasis
was achieved by local pressure alone. Especially after large
(12F) sheath removal, prolonged (30 min) manual com-
pression was applied, followed by overnight bed rest.
The stents used included 11 self expanding Sinus-XL
(diameter, 14-18 mm; length, 40-60 mm; OptiMed, Et-
tlingen, Germany), and two Palmaz P 4014 and two
Palmaz P5014 balloon-expandable aortic stents (Cordis,
Johnson & Johnson, Warren, NJ) were placed, with the
latter being preferred in heavily calcified lesions. A total of
15 Sinus 6F (OptiMed) self-expanding iliac stents were
used (diameter, 8-9 mm; length, 40-80 mm). Aortic stents
were placed so that they would not limit future open repair
if needed. Stent sizing was based on the lumen diameter of
the native healthy aorta just proximal or distal to the lesion
that was measured on the preprocedural angiogram. Self-
expanding stents were oversized up to 5%. The stent length
chosen was the shortest one appropriate for complete cov-
erage of the lesion and adequate proximal and distal attach-
ment to healthy aortic segments.
After the procedure, double antiplatelet treatment with
aspirin (100mg/d) and clopidogrel (75mg/d) was admin-
istered for 1 month, and then monotherapy with clopi-
dogrel (75 mg/d) was continued long term unless contra-
indicated.
Technical success was obtained if the residual stenosis
as measured on angiogram was30% or the mean pressure
gradient across the lesion was 10 mm Hg.17 Immediate
hemodynamic success was determined by an increase in
ABI of 0.10 from baseline at the first clinical follow-up.18
Clinical success was defined as improvement in walking
distance, absence of resting pain, and healing of trophic
changes after stent placement.19
After stent deployment, femoral pulses were palpated
and ABIs at rest were measured in all patients. Follow-up at
1, 3, and 6months postprocedure and biannually thereafter
included physical examination, ABI measurements, and
duplex ultrasound (DUS) scanning. Clinical patency was
defined as the continued absence or improvement of symp-
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scan.16,17 During the latter, the whole stented segment was
scanned to locate areas with high peak systolic velocities,
which were then compared with the velocities recorded
immediately upstream and downstream. The value of the
highest proportional velocity change was used as the crite-
rion for stenosis grading. For a 50% aortoiliac stenosis, a
peak systolic velocity ratio 2.5 was used.
Angiography was performed only in cases of recurrent
stenosis 50% as measured on DUS scans combined with
deterioration in walking distance. Two patients underwent
follow-up angiography concomitantly with angiographic
evaluation for carotid artery disease.
Statistical analysis was done with SPSS 10.0 software
(SPSS Inc, Chicago, Ill). The persistence of patency during
follow-up was reported by Kaplan-Meier life-table analysis.
The preprocedural and postprocedural ABIs were com-
pared by Student t test. Statistical significance was taken
at P  .05.
RESULTS
Patients’ characteristics are summarized in Table I. Six
patients (50%) were men. The mean age was 66.3 years
(range, 62-73 years). Three patients (25%) had chronic
renal failure and were receiving dialysis. Six patients (50%)
were referred because of severe claudication (Rutherford
Classification20 - Category 3) 4 patients (33.3%) due to
ischemic rest pain (Category 4) and 2 patients (16.7%) due
to minor tissue loss (Category 5). Preprocedural mean
resting ABIs were 0.56  0.13 at the right side and 0.59
 0.15 at the left side. In the eight patients with patent
aortas, mean aortic stenosis before the procedure was
71% (range, 60%-85%).
Four patients with localized stenosis at the mid portion
of the infrarenal aorta were treated with primary aortic
stenting (Fig 1), whereas in two patients with distal aortic
stenosis close to but not involving the aortic bifurcation,
iliac kissing stents were placed. Four patients with chronic
total aortobiiliac occlusion were treated with aortic stents
and iliac kissing stents that were deployed contiguously
(Figs 2 and 3). Three of these patients were judged poor
surgical candidates: one had coronary artery disease with
impaired ejection fraction, one was obese with severe
chronic obstructive pulmonary disease due to heavy smok-
ing, and one had a hostile abdomen due to previous oper-
ations. One patient refused open surgery.
One patient with localized infrarenal aortic stenosis and
right CIA and EIA chronic occlusion extending to the CFA
underwent aortic stenting and a femorofemoral bypass
graft. Finally, one patient with two separate localized iso-
lated stenoses at the infrarenal aorta, chronic left CIA and
EIA occlusion, and right CIA stenosis, underwent aortou-
niiliac stenting with three stents (two aortic, one iliac),
along with a femorofemoral bypass graft. Actually, no
attempts for endovascular recanalization of the iliac occlu-
sions were made in these two patients owing to anatomic
limitations (restricted working length for sheath and wireinsertion in the CFA) and theoretic concerns (increased
possibility of damage stent placed in the CFA due to the
repeated motions of the hip joint).
Technical success was obtained in 11 of 12 patients
(91.7%). One patient was considered to be immediate
technical failure. This hypertensive and hypercholester-
olemic 62-year-old man with chronic renal failure was
admitted with severe claudication (Rutherford category 3)
caused by right common iliac artery stenosis and left iliac
segment occlusion (TASC D). He had good distal run-off
with two patent crural arteries. Despite aortic stenting
and balloon postdilation, the aortic stenoses were not
completely dilated owing to severe calcification, thus
resulting in an immediate technical failure with residual
stenoses 30%.
Clinical success, however, was 100% immediately after
the procedure. The six patients with severe claudication,
including the one with residual stenosis 30%, reported
improvement in walking distance. Four patients who had
resting pain before the procedure reported they were free
of their symptoms postoperatively, and bilateral trophic
changes in the remaining two patients were healed com-
pletely 4 months after the procedure.
Immediate hemodynamic success was 100%. After the
procedure, the mean resting ABI increased to 0.97 0.04
at the right side and to 0.95 0.06 at the left side (P .01
compared with preinterventional values).
No deaths occurred 30 days after stent implantation,
nor were there any aortic ruptures or any other major
Table I. Population characteristics and preinterventional
clinical classification
Characteristic Mean  SD, or No. (%)
Age, y 66.3  4.1
Sex
Males 6 (50)
Females 6 (50)
Cardiovascular risk factors
Smoking 9 (75)
Hypertension 5 (41.7)
Diabetes mellitus 4 (33.3)
Hypercholesterolemia 7 (58.3)
Chronic renal failure* 3 (25)
Preintervention categories by
Rutherford classification†
1 (mild claudication) 0 (0)
2 (moderate claudication) 0 (0)
3 (severe claudication) 6 (50)
4 (ischemic rest pain) 4 (33.3)
5 (minor tissue loss) 2 (16.7)
6 (major tissue loss) 0 (0)
*Patient on dialysis.
†Category 1, treadmill exercise completed (5 min at 2 mph on a 12%
incline), postexercise ankle pressure (AP)50mmHg but25mmHg less
than normal; category 2, symptoms between categories 1 and 3; category 3,
treadmill exercise cannot be completed, postexercise AP 50 mm Hg;
category 4, resting AP of 40 mm Hg; category 5, nonhealing ulcer, focal
gangrene; category 6, extending above the transmetatarsal level, functional
foot no longer salvageable.complications. A minor groin hematoma that developed in
of a b
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any further intervention. No other early complications
occurred in this series.
During a mean follow-up of 18.3 months (range, 6-37
months), the stented arteries remained patent in all but one
patient, a 73-year-old woman who was a heavy smoker,
hypertensive, and hypercholesterolemic. She initially had
severe bilateral claudication (Rutherford category 3) due to
chronic aortobiiliac occlusion (TASC D). She had good
distal run-off with three patent crural arteries. The patient
was treated successfully with two aortic and two iliac kissing
stents. She had a notable clinical improvement after the
procedure; however, she returned 4 months postopera-
Fig 1. A, Digital subtraction angiography demonstrate
transversed with a long sheath.B, Successful deployment
Fig 2. A, Preprocedural digital subtraction angiography
two aortic and iliac stents deployed contiguously. C, At
widely patent.tively with recurrent left lower extremity ischemia owing toleft common iliac artery reocclusion. Although she refused
reintervention despite our suggestions, her left lower ex-
tremity remained viable without any significant trophic
changes until the most recent follow-up. In the rest of the
patients, DUS imaging did not reveal any other restenosis
in any of the stented arteries during the follow-up period.
One patient died 8 months after the procedure of compli-
cations from chronic renal failure.
Kaplan-Meier life-table analysis of primary patency is
shown in Fig 4. At the end of follow-up, the primary clinical
and hemodynamic patency was 91.7%  7.98%. Post-
interventional ABI improvement was maintained for the
whole graphed time period. Themean resting ABI values at
ated stenosis at the mid-portion of the infrarenal aorta
alloon-expandable aortic stent without residual stenosis.
onstrates total aortobiiliac occlusion. B, Treatment with
onths postoperatively, the aortic and iliac stents remains isoldem
9 mthe most recent available follow-up were 0.96  0.04 for
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compared with preinterventional values).
No patients in this series underwent reintervention
during the follow-up period.
Mean hospitalization time after stent placement was
2.3  1.37 days. Three patients were hospitalized for 1 day,
six for 2 days, and one for 3 days owing to an access site
hematoma. Finally, two patients who underwent a femoro-
femoral bypass in addition to stent placement were dis-
charged 5 days postoperatively.
In summary, two treatment failures were noticed in this
series: one immediate technical failure due to residual ste-
nosis 30% and one late failure secondary to an iliac stent
Fig 3. A, Total aortobiiliac occlusion treated success
common iliac arteries.
Fig 4. Kaplan-Meier life-table analysis of primary patency after
stenting of aortic localized stenoses and total occlusions.reocclusion.DISCUSSION
Focal stenosis or occlusion of the infrarenal aorta is a
relatively rare entity.16 It most commonly affects younger
patients with less extensive atherosclerotic lesions com-
pared with those who have iliofemoral or more distal dis-
ease.19 Female sex, heavy smoking, elevated blood lipid
concentrations, and the hypoplastic aorta syndrome are
among the most important risk factors.1,19,21
Aortobifemoral bypass or aortic endarterectomy has
been the traditional treatment of choice for infrarenal aortic
occlusive disease with well-documented long term re-
sults,2-4 In carefully selected patients, the 11-year cumula-
tive patency rate after localized endarterectomy of the
abdominal aorta is 86 %,4 whereas long-term patency after
aortobifemoral bypass is reported to be up to 90% at 5 years
and 75% at 10 years.22,23 These procedures, however, are as-
sociated with significant morbidity and mortality24-26 and
may also lead to sexual dysfunction in up to a third of
men.27
PTA, which was initially introduced for aortic lesions in
1980 by Grollmann et al,28 Velasquez et al,29 and Tegtm-
eyer et al,30 has been proposed as an alternative to surgery.
Since then, several series have been published demonstrat-
ing successful results of PTA in localized stenoses involving
the infrarenal aorta5-11 as well as the aortic bifurcation.5-7,10
Aortic PTA has a satisfactory immediate outcome, with
initial technical success up to 95% to 100%7,19,31; however,
its mid- and long-term efficacy is frequently compromised
due to restenosis.10
Stenting may overcome the suboptimal results of PTA.
Although to our knowledge to date no prospective ran-
domized trials have compared the two techniques, stent
implantation is theoretically superior to PTA because it
provides a smooth cylindrical lumen that favors nonturbu-
with primary stenting of the (B) infrarenal aorta andfullylent flow, thus minimizing the possibility of thrombus
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addition, stenting reduces the recoil effect after PTA, espe-
cially in calcified “hard” aortic lesions, whereas the conse-
quences of in-stent neointimal hyperplasia are not so crucial
in a large diameter vessel such as the aorta.
Unlike the iliofemoral territory, stenting has been in-
frequently documented in the infrarenal aorta. First, Di-
ethrich et al13 began in 1990 to offer stent therapy to
patients with abdominal aortic lesions that were considered
to be at high risk for conventional surgery. In 24 patients,
they reported a 100% cumulative primary patency at 5
years. Since then, a limited number of series have studied
the efficacy of stent placement in the infrarenal aorta.
Technical success in these studies was 82% to 100%,
whereas primary patency rates were 83% to 100% during the
short- and mid-term follow-up.13,15-17,32-37
In most of these series, aortic stents were implanted
after predilation. In our study, however, all eight patients
who had localized aortic stenoses were treated successfully
with direct stenting without predilation. Covering the le-
sion with a stent before angioplasty may reduce the possi-
bility of distal embolization because the potentially embolic
material is trapped between the stent and the arterial wall.
In addition, stenting without predilation, although not
clinically proven, may minimize the risk of vessel rupture by
distributing the dilating forces more evenly against the
aortic wall.32 Direct stenting therefore may be preferable to
stent implantation after predilation.
To our knowledge, only five small studies with a total of
93 patents have been published in English reporting direct
aortic stenting without predilation (Table II).17,32-37 Pro-
spective randomized studies are necessary to definitely clar-
ify this issue; however, because such evidence is not cur-
rently available, the decision regarding predilation of the
aorta is based mainly on arbitrary data and physicians’
personal opinions.
Four patients with chronic total aortobiiliac occlusion
were treated successfully (PTA plus stenting) without pre-
vious thrombolysis in this series. Although stenting of total
aortic occlusions after initial thrombolysis has been re-
ported relatively frequently,14,16,33,34,38 apart from the
present study, only one case series39 has documented suc-
cessful recanalization and stenting of extended total aorto-
biiliac occlusions without adjunctive thrombolytic therapy.
Table II. Results of direct stenting for distal aortic occlus
First author Year
No of
cases Age (range)*
Stenosis/
occlusion
Sheeran.35 1997 9 61 (49-73) 9/0 
Nyman.33 2000 30 61 (42-80) 21/9 
Yilmaz.32 2004 13 57 13/0 
Schedel17 2004 15 54 (46-62) 15/0 
Poncyljusz37 2006 26 57 (43-72) 26/0 
Present study 12 66.3 (62-73) 8/4
*Mean and median age as provided by each author.The latter, although commonly useful in acute or subacuteobstructions, has an unpredictable efficacy in chronic oc-
clusions.40 Thrombolytic therapy is also associated with an
increased risk for hemorrhage: bleeding from venous punc-
ture sites occurs in up to 68% of the patients,40 and groin
hematomas and fatal hemorrhage have also been reported.33,41
As a consequence, we avoided thrombolysis in our patients
and proceeded directly with PTA and stenting. Recanaliza-
tion was achieved in all four cases, thus implying a promis-
ing role of primary stenting without thrombolysis even for
TASC D41 chronic total aortoiliac occlusions. Further
studies with larger number of patients are needed to con-
firm these findings.
Self-expanding aortic stents were used in most of the
patients in this series. The latter, due to their continuous
radial force, may achieve gradual expansion after balloon
widening, allowing for the use of smaller-sized balloons
and thus minimizing the risk of aortic rupture. Self-expanding
endoprostheses may also trap atherothrombotic material
more effectively owing to their smaller struts and theo-
retically reducing the possibility of distal embolization,32
which is probably more likely to occur in noncalcified
“soft” aortic plaques and total aortic occlusions. Finally, for
iliac artery lesions, only self-expanding stents were used
owing to their superior flexibility and ability to adapt to
vessel tortuosity.39
Balloon-expandable stents were placed preferentially in
patients with calcified aortic lesions. It is considered that
such stents perform better in highly calcified “hard” aortic
plaques because of their enhanced radial force.33 In addi-
tion, placement of a self-expanding stent on hard calcified
lesions without predilation may lead to incomplete deploy-
ment of its edges, especially if the stent is not centered on
the lesion or its length is not sufficient enough to cover
both proximal and distal healthy sides of the aorta (Fig 5, D
and E). It is therefore suggested that if self-expanding
stents are selected to treat calcified aortic stenoses, they
should be centered on the lesion. In addition, their length
should be greater than the lesions they are intended to
cover in order to secure complete deployment of their
edges and subsequently allow for safe balloon catheter
advancement (Fig 5, A and C).
As mentioned, patients who have aortic occlusive dis-
ease are relatively young, have a longer life expectancy
compared with the average patient with claudication, and
isease
Technical
success (%)
Major
complications
Mean follow-up,
mon (range)
Primary
patency (%)
100 0 19 (2-36) 89
93 4 19 (5-60) 97
100 0 43 (12-96) 100
87 3 36 (12-46) 85
100 0 18 (12-24) 100
91.7 0 18 (6-37) 91.7ive dthus are more likely to need secondary interventions.21 In
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with less technical difficulties compared with surgical revi-
sion in a previously operated on field with scar tissue and
distorted anatomy. Thus, endovascular therapy may be
advantageous in this patient group and might be consid-
ered the treatment of choice.
No symptoms of mesenteric ischemia developed post-
operatively in any of the patients in this series. Although
one could argue that implantation of a stent across the
inferior mesenteric artery (IMA) should be avoided, we
believe that this is not routinely a major factor in stent
placement, because patency of this artery is usually main-
tained despite enjailment of its ostia.36,38 But even if the
IMA is occluded after stent placement, it should be consid-
ered acceptable as long as the patient remains asymptomatic
Fig 5. A, Drawing shows eccentric calcified aortic stenosis. B,
Placement of a self-expanding stent, centered on the lesion, with
adequate length achieving complete deployment of its edges in
healthy aortic segments. C, Successful postdilation of the stented
lesion.D, Inappropriate placement of a noncentered, small-length,
self-expanding stent results in (E) difficulties in subsequent bal-
loon catheter advancement due to incomplete deployment of its
distal edge.because during aortic surgery, the IMA is commonly sacri-ficed as part of the procedure. Only in cases of superior
mesenteric/celiac artery occlusive disease, enlarged and
meandering IMA, or bilateral hypogastric artery occlusion,
stent covering of the IMA orifice should be avoided. In any
case, efforts should be made to place the stents away from
the IMA orifice. In patients in whom this is not possible,
angiographic evaluation of the superior mesenteric, celiac,
and hypogastric arteries is necessary.
The one technical failure in these series was due to
severe aortic calcification that precluded complete aortic
dilation and resulted in residual stenosis 30%. This patient
had undergone a magnetic resonance angiography before
being referred to our department for interventional treat-
ment, and we proceeded with aortic stenting and dilation
without performing a computed tomography scan. Al-
though the patient benefited from our intervention, be-
cause he had clinical and hemodynamic success with im-
provement of symptoms and ABIs, it should be mentioned
that a preoperative computed tomography scan would have
been helpful in documenting the amount of calcification
and predicting the risk of inability to dilate this aortic
lesion.
This study reports successful primary stenting for the
whole spectrum of aortic occlusive disease, ranging from
isolated aortic stenoses to total chronic aortobiiliac occlu-
sions. Both these lesions were included in the recently
published TASC II classification.41 On the basis of excel-
lent technical success rates and long-term outcomes of
percutaneous treatment reported by several pioneer
groups,14-16,34 short focal infrarenal aortic stenosis was
placed in the TASC B category, whereas infrarenal aor-
toiliac occlusion was included in TASC D category accord-
ing to the latest available data.
The findings of our study are in agreement with the
TASC II classification regarding focal aortic stenoses
(TASC B), although they also imply a beneficial role of
endovascular treatment for chronic total aortoiliac occlu-
sions, which are classified as TASC D and thus considered
to be best treated by open surgery. In our opinion, al-
though current evidence supports an open surgical ap-
proach to total aortoiliac occlusions, endovascular therapy
should not be excluded because it may be appropriate in
selected patients.
CONCLUSION
Our results support the feasibility, safety, and efficacy of
primary stenting for stenoses and occlusions of the distal
infrarenal aorta. Although larger prospective randomized
studies with long-term follow-up are necessary to compare
surgery, PTA, and primary stent placement, our prelimi-
nary findings along with that of other series indicate that
primary stenting may have a significant role in the manage-
ment of the whole range of infrarenal aortic occlusive
disease. Particularly for infrarenal aortic stenoses, it is rec-
ommended as the first-line treatment option, whereas for
total aortoiliac occlusions, it should be considered as a
reasonable alternative to surgery.
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